Type 2 Diabetes and Brain Health: What Recent Studies on Blood Sugar and Medications Can—and Cannot—Tell Us
Type 2 diabetes is often discussed through blood glucose, weight, A1c, blood pressure, or cholesterol. Those measures matter. But people living with diabetes are also asking a broader question: What does metabolic health mean for the brain over time? Brain health belongs in the type 2 diabetes conversation That question has become more urgent as […]
GLP-1s After 60: Why Medication Decisions Must Protect Strength, Function, and Independence
Source note: This article was prompted by reporting on GLP-1 medicines and aging, plus a commentary on the history of weight-loss culture. The question is not simply “Will it cause weight loss?” GLP-1 receptor agonists have changed the conversation around obesity and type 2 diabetes. These medicines can improve glucose control in people with type […]